PONDS NP CLARANT B3 CRA 50G BORICO 276M89 SSA

Description

276M89 SSA

Prevención de eventos esqueléticos en pacientes con metástasis óseas por tumores sólidos

Características de ERBITRAX-T:

Información disponible según registro sanitario

20 ML Solución Gotero

PONDS NP CLARANT B3 CRA 50G BORICO 276M89 SSADOSIS: 50 G FORMA FARMACUTICA: 1 CREMA CORPORAL PRESENTACIN: 1 ENVASE

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy